---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-032951"
form_type: "8-K"
ticker: "CRNX"
cik: "0001658247"
company_name: "Crinetics Pharmaceuticals, Inc."
filed_at: "2026-08-14T12:30:52+00:00"
generated_at: "2026-08-14T12:35:18.708139+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Crinetics-Vertex merger clears HSR and key antitrust hurdles; close expected early Sept

## Summary
- HSR waiting period expired Aug 12, 2026 at 12:45 p.m. ET.
- Antitrust approvals received in Austria, Germany, Australia; Australia waiting period expires Aug 27, 2026.
- Shareholder vote scheduled for Aug 28, 2026; merger expected to close early September 2026.
- Deal projected to support >$5B annual revenue and be accretive to non-GAAP operating income in 2029.

## SEC filing metadata
- accession: 0001140361-26-032951
- form_type: 8-K
- ticker: CRNX
- cik: 0001658247
- company_name: Crinetics Pharmaceuticals, Inc.
- filed_at: 2026-08-14T12:30:52+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658247/000114036126032951/0001140361-26-032951-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658247/000114036126032951/ef20080199_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-032951
- JSON: https://secwatch.observer/filing/0001140361-26-032951.json
- Plain text: https://secwatch.observer/filing/0001140361-26-032951.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.